Safety established in all doses1



ADVERSE REACTIONS ≥2% FOR QULIPTA AND GREATER THAN PLACEBO |
Placebo (n=408) | QULIPTA 10 mg QD (n=314) |
QULIPTA 30 mg QD (n=411) |
QULIPTA 60 mg QD (n=417) |
---|---|---|---|---|
Nausea | 3% | 5% | 6% | 9% |
Constipation | 1% | 6% | 6% | 6% |
Fatigue/Somnolence | 3% | 4% | 4% | 6% |
Decreased appetite | <1% | 2% | 1% | 2% |



A DECREASE IN WEIGHT WAS OBSERVED1
The proportion of patients with a weight decrease of at least 7% at any point was 4.9% for QULIPTA 60 mg, 3.2% for QULIPTA 30 mg, 3.8% for QULIPTA 10 mg, and 2.8% for placebo.1
SEE EFFICACY RESULTS